Tenlimac M 500 Tablet SR

Description

Tenlimac M 500 Tablet SR is a combination oral antidiabetic medication containing Metformin and Teneligliptin.

• Metformin (500mg): A biguanide that reduces glucose production in the liver and improves insulin sensitivity, lowering blood sugar levels.

• Teneligliptin (20mg): A DPP-4 inhibitor that enhances insulin secretion and reduces glucagon release after meals, improving glycemic control.

The SR (sustained-release) formulation provides stable plasma drug levels, reduces gastrointestinal side effects, and allows for once-daily dosing.

---

Uses

Tenlimac M 500 Tablet SR is prescribed for:

• Management of type 2 diabetes mellitus

• Patients not adequately controlled by Metformin or Teneligliptin alone

• Improving fasting and postprandial blood glucose

• Long-term glycemic control

---

Advantages

• Dual mechanism of action for enhanced blood sugar control

• Sustained-release formulation reduces gastrointestinal discomfort

• Can be used as monotherapy or in combination with other antidiabetic agents

• Convenient once-daily dosing improves patient compliance

---

Possible Side Effects

Common side effects:

• Gastrointestinal discomfort (nausea, diarrhea, abdominal pain)

• Mild headache

• Rare allergic reactions

Rare but serious side effects:

• Lactic acidosis (rare, especially in kidney or liver impairment)

• Severe hypoglycemia (when combined with other antidiabetic drugs)

• Pancreatitis (rare)

---

Precautions

• Take as prescribed, preferably with meals to reduce gastrointestinal side effects

• Regularly monitor blood sugar levels

• Inform your doctor if you have kidney, liver, or heart disease

• Not suitable for type 1 diabetes or diabetic ketoacidosis

• Seek medical attention for unusual abdominal pain or signs of hypoglycemia